1 Min Read
Jan 31 (Reuters) - Protalix Biotherapeutics Inc:
* PROTALIX BIOTHERAPEUTICS’ PEGUNIGALSIDASE ALFA RECEIVES FAST TRACK DESIGNATION FROM THE U.S. FOOD AND DRUG ADMINISTRATION Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.